Postoperative radiation therapy for patients who have resected non-small cell lung cancer

Keyphrases

• Survival Benefit 100%
• Resectable Lung Cancer 100%
• Intraoperative Radiation Therapy 100%
• Meta-analysis 50%
• Non-small Cell Lung Cancer (NSCLC) 50%
• Potential Gains 50%
• Clinical Analysis 50%
• Analysis Support 50%
• Central Nervous System Relapse 50%
• N2 Disease 50%
• N1 Disease 50%
• Large Trials 50%
• Postoperative Therapy 50%
• Prophylactic Cranial Irradiation 50%

Medicine and Dentistry

• Non Small Cell Lung Cancer 100%
• Radiation Therapy 100%
• Diseases 66%
• Meta-Analysis 33%
• Central Nervous System 33%
• Adjuvant Chemotherapy 33%
• Postoperative Care 33%
• Group Trial 33%
• Prophylactic Cranial Irradiation 33%